NechelesT., BolesT., and AllenD.: Erythrocyte Glutathione-Peroxidase Deficiency and Hemolytic Disease of the Newborn Infant, J. Pediat.72: 319 (Mar.) 1968.
6.
SteinbergM., and NechelesT.: Erythrocyte Glutathione-Peroxidase Deficiency, Am. J. Med.50: 542 (Apr.) 1971.
7.
SteinbergM., BrewerM., and NechelesT.: Acute Hemolytic Anemia Associated with Erythrocyte Glutathione-Peroxidase Deficiency, Arch. Intern. Med.125: 302 (Feb.) 1970.
8.
HarrisJ. W.: Studies on the Mechanisms of a Drug-Induced Hemolytic Anemia, J. Lab. Clin. Med.44: 809 (Nov.) 1954.
9.
HarrisJ. W.: Studies on the Mechanisms of a Drug-Induced Hemolytic Anemia, J. Lab. Clin. Med.47: 760 (May) 1956.
10.
BoveJ. R.: Coombs (Antiglobulin) Test, J. Am. Med. Assoc.200: 459 (May) 1967.
11.
GillilandB. C., BaxterE., and EvansR. S.: Red Cell Antibodies in Acquired Hemolytic Anemia with Negative Antiglobulin Serum Tests, N. E. J. Med.285: 252 (July) 1971.
LogueG. L., and BoydA. E.: Chlorpropamide-Induced Immune Hemolytic Anemia, N. E. J. Med.283: 900 (Oct.) 1970.
15.
DernR. J., BeutlerE., and AlvingA. S.: The Hemolytic Effect of Primaquine, J. Lab. Clin. Med.45: 30 (Jan.) 1955.
16.
AlvingA. S., KellermeyerR. W., TarlovA., SchrierS. L., and CarsonP.: Biochemical and Genetic Aspects of Primaquine-Sensitive Hemolytic Anemia, Ann. Intern. Med.45: 240, 1958.
17.
MuirheadE. E., HaldenE. R., and GrovesM.: Drug-Dependent Coombs' Test and Anemia, Arch. Intern. Med.101: 87 (Jan.) 1958.
18.
HoustenI. B., and BarlowA. M.: Acute Hemolytic Anemia and Methemoglobinemia Produced by Phenacetin, Lancet2: 1062 (Dec.) 1960.
19.
MacGibbonB., LoughridgeL. W., HourihaneD., and BoydD. W.: Auto-Immune Hemolytic Anemia with Acute Renal Failure Due to Phenacetin and p-aminosalicylic acid, Lancet1: 7 (Jan.) 1960.
20.
LorenzenI., and SchwartzM.: Phenacetin Induced Hemolysis in Patients with Chronic Nephritis and Phenacetin Abuse, Acta. Med. Scand.168: 461 (July) 1960.
21.
GillesH. M., and TaylorB. F.: The Existence of the Glucose-6-Phosphate Dehydrogenase Deficiency Trial in Nigeria and Its Clinical Implications, Ann. Trop. Med. Parasitol.55: 64 (Jan.) 1961.
22.
DaussetJr., and ContuL.: A Case of Hemolytic Anemia Due to Phenacetin Allergy, Vox Sang.6: 91, 1961.
23.
HutchisonH. E., JacksonJ. M., and CassidyP.: Phenacetin-Induced Hemolytic Anemia, Lancet2: 1022 (Nov.) 1962.
24.
DaussetJ., and ContuL.: A Case of Hemolytic Anemia Due to Phenacetin Allergy, Vox Sang9: 599 (Sept.-Oct.) 1964.
25.
WallersteinR. O., and AggelerP. M.: Acute Hemolytic Anemia, Am. J. Med.37: 92 (July) 1964.
26.
HartM. N., and MesaraB.: Phenacetin Antibody Cross-Reactive with Auto-immune Erythrocyte Antibody, Am. J. Clin. Path.52: 695 (Dec.) 1969.
27.
AzenE. A., BryanG. T., ShahidiN. T., RossiE. C., and ClatanoffD. V.: Obscure Hemolytic Anemia Due to Analgesic Abuse, Am. J. Med.48: 724 (June) 1970.
28.
BoustaniA., and MichotF.: Phenacetin Induced Immune-Hemolytic Anemia of the Innocent Bystander Reaction Type, Schweiz. Med. Wschr.100: 1650, 1970.
29.
SchnitzerB.: Analgesics, Hemolysis and Splenomegaly, Ann. Intern. Med.75: 320 (Aug.) 1971.
30.
BirdG. W., EelesG. H., HitchfieldJ.A.: Haemolytic Anemia Associated with Antibodies to Tolbutamide and Phenacetin, Brit. Med. J.1: 728 (Mar.) 1972.
31.
MillarJ., PeloquinR., and de LeewrN.K.M.: Phenacetin-Induced Hemolytic Anemia, Calif. Med. Assoc. J.106: 770 (Apr.) 1972.
32.
Van LoghenJ. J.Jr.: Auto-immune Hemolytic Anemia With Renal Failure Due to Phenacetin and P.A.S., Lancet1: 434 (Feb) 1960.
33.
SzeimbergA., ShebaC., HirshornN., and BodonyiE.: Studies on Erythrocytes in Cases With Past History of Favism and Drug-Induced Acute Hemolytic Anemia, Blood12: 603 (July) 1957.
34.
ClapsF.: Two Cases of Methemoglobinemia and Acute Hemolytic Anemia With Death Following the Ingestion of a Solution of p-Amino Salicylic Acid, Am. Rev. Tuber.76: 862 (Nov.) 1957.
BowerG.: Skin Rash, Hepatitis and Hemolytic Anemia Caused by p-Aminosalicylic Acid, Am. Rev. Resp. Dis.89: 440 (Mar.) 1964.
37.
MunroeW. D., LawsonW. J., and HolcombT. M.: Hemolytic Anemia Due to Salicylic Acid, Am. J. Dis. Child.108: 425 (Oct.) 1964.
38.
LesobreB., HombergJ. C., SegarJ., KourilskyR., and PieronR.: Duex Observation de Deficit en Glucose-6-Phosphate Deshydrogenase Revele au Cours d'un Traitement par l'Acide p-Aminosalicylique, Sem. Hop. (Paris)20: 1361 (Apr.) 1970.
HolemanC. W., and EinsteinH.: The Toxic Effects of Amphotericin B in Man, Calif. Med.99: 90 (Aug.) 1963.
42.
BohenenR. F., UltmannJ. E., GormanJ. G., FarhangiM., and ScudalerJ.: The Direct Coombs Test: Its Clinical Significance, Ann. Intern. Med.68: 19 (Jan) 1968.
43.
SpolyarL. W., and HargerR. N.: Arsine Poisoning, Arch. Hyg. Occup. Med.1: 419 (Apr.) 1950.
44.
PintoS. S., PetronellaS. J., JohnsD. R., and ArnoldM. F.: Arsine Poisoning, a Study of Thirteen Cases, Arch. Hyg. Occup. Med.1: 437 (Apr.) 1950.
45.
MorseK. M., and SetterlindA. N.: Arsine Poisoning in the Smelting and Refining Industry, Arch. Indust. Hyg2: 148 (Aug.) 1950.
NeuwirtovaR., ChythM., ValekA., DaumS., and ValachV.: Acute Renal Failure Following an Occupational Intoxication With Arsine Treated by the Artificial Kidney, Acta. Med. Scand.170: 535 (Nov.) 1961.
48.
JenkinsG. C., IndJ. E., KazantzisG., and OwenR.: Arsine Poisoning: Massive Hemolysis With Minimal Impairment of Renal Function, Brit. Med. J.2: 78 (July) 1965.
BurkaE. R., WeaverZ., and MarksP.: Clinical Spectrum of Hemolytic Anemia Associated With Glucose-6-Phosphate Dehydrogenase Deficiency, Ann. Intern. Med.64: 817 (Apr.) 1966.
53.
KellermeyerR. W., TarlovA. R., SchrierS., and AlvingA.: Hemolytic Effect of Commonly Used Drugs on Erythrocytes Deficient in Glucose-6-Phosphate Dehydrogenase, J. Lab. Clin. Med.52: 827 (Nov.) 1958.
54.
SzeinbergA., KellermanJ., AdamA., ShebaC., and RamotB.: Hemolytic Jaundice Following Aspirin Administration to a Patient With a Deficiency of Glucose-6-Phosphate Dehydrogenase in Erythrocytes, Acta Hematol.23: 58 (Jan.) 1960.
55.
WestringD., and PisciottaA.: Anemia, Cataracts and Seizures in Patients With Glucose-6-Phosphate Dehydrogenase Deficiency, Arch. Intern. Med.118: 385 (Oct.) 1966.
56.
ShahidiN. T., and WestringD. W.: Acetylsalicylic Acid-Induced Hemolysis and Its Mechanism, J. Clin. Invest.49: 1334 (July) 1970.
57.
HarlyJ. D., RobinH., and RobertsonS. E.: Thiazide Induced Neonatal Hemolysis?Brit. Med. J.1: 696 (Mar.) 1964.
58.
ErfL. A., and RhoadsC. P.: The Hematological Effects of Benzene Poisoning, J. Indus. Hyg. Toxicol.21: 421 (Oct.) 1939.
59.
FassR. J., PerkinsR., and SaslawS.: Positive Direct Coombs' Studies After Cephaloridine and Cephalexin, Clin. Res.17: 539 (Oct.) 1969.
60.
FassR. J., PerkinsR., and SaslawS.: Cephalexin, a New Oral Cephalosporin: Clinical Evaluation in Fifty-Four Patients, Ohio Med. J.66: 253 (Mar.) 1970.
61.
FassR. J., PerkinsR. L., and SaslawS.: Cephalexin, a new Oral Cephalsporin: Clinical Evaluation in Sixty-Three Patients, Am. J. Med. Sci.259: 187 (Mar.) 1970.
62.
ErikssenJ., MidvedtT., and BerganT.: Treatment of Urinary Tract Infections With Cephalexin, Scand. J. Infec. Dis.2: 53, 1970.
63.
ForbesC. D., CraigJ. A., MitchellR.: Acute Intravascular Hemolysis Associated With Cephalexin Therapy, Postgrad. Med. J.48: 186 (Mar.) 1972.
64.
PerkinsR. L., MengelC. E., and SaslawS.: Direct Coombs', Reactivity After Cephalothin or Cephaloridine in Man and Monkey, Proc. Soc. Exp. Biol. Med.129: 397 (Nov.) 1968.
65.
YorkR. P., LandesR. R., and SeayL. S.: Coombs' Positive Reactions Associated With Cephaloridine Therapy, J. Am. Med. Assoc.206: 1086 (Oct.) 1968.
FassR. J., PerkinsR. L., and SaslowS.: Positive Direct Coombs' Test Associated With Cephaloridine Therapy, J. Am. Med. Assoc.213: 121 (July) 1970.
68.
MolthanL., ReidenbergM., and EichmanM.: Positive Direct Coombs' Tests Due to Cephalothin, N. E. J. Med.277: 123 (July) 1967.
69.
GralnickH. R., WrightL. D., and McGinnissM. H.: Coombs' Positive Reactions Associated With Sodium Cephalothin Therapy, J. Am. Med. Assoc.199: 725 (Mar.) 1967.
70.
GralnickH. R., McGinnissM. H., EltonW., and McCurdyP.: Hemolytic Anemia Associated With Cephalothin Therapy, J. Am. Med. Assoc.217: 1193 (Aug.) 1971.
71.
FreymanJ. G., BurrellS. B., and MarlerE. A.: Role of Hemolysis in Anemia Secondary to Chronic Lymphocytic Leukemia and Certain Malignant Lymphomas, N. E. J. Med.255: 847 (Oct.) 1958.
72.
DameshekW., and GunzF.: Leukemia.New York: Grune & Stratton, pp. 324 and 417, 1964.
73.
DavidsohnI., and SpurrierW.: Immunohemolytic Studies in Hemolytic Anemia, J. Am. Med. Assoc.154: 818 (Mar.) 1954.
ChatterjiS. C., and DasP. K.: Chloramphenicol Induced Hemolytic Anemia Due to Enzymatic Deficiency of Erythrocytes, J. Indian Med. Assoc.40: 172 (Feb.) 1963.
76.
BerryD. H., and ViettiT. J.: Primaquine Anemia, Am. J. Dis. Child.110: 166 (Aug.) 1965.
77.
HerskoC., and VardyP. A.: Hemolysis in Typhoid Fever in Children With G-6-PD Deficiency, Brit. Med. J.1: 214 (Jan.) 1967.
78.
RobertsonR. P., WahabM. F. A., and RaaschF. O.: Evaluation of Chloramphenicol and Ampicillin in Salmonella Enteric Fever, N. E. J. Med.278: 171 (Jan.) 1968.
79.
McCafferyR. P., HalstedC. H., WahabM. F. A., and RobertsonP.: Chloramphenicol Induced Hemolysis in Caucasian Glucose-6-Phosphate Dehydrogenase Deficiency, Ann. Intern. Med.74: 722 (May) 1971.
80.
JacksonR. C., ElderW. J., and McDonnellH.: Sodium Chlorate Poisoning Complicated by Acute Renal Failure, Lancet2: 1381 (Dec.) 1961.
81.
KlendshojN. C., BurkeW. J., AnthoneR., and AnthoneS.: Chlorate Poisoning, J. Am. Med. Assoc.180: 1133 (June) 1962.
82.
KnightR. K., TrounceJ. R., and CameronJ. S.: Suicidal Chlorate Poisoning Treated With Peritoneal Dialysis, Brit. Med. J.3: 701 (Sept.) 1967.
83.
LeeD. B. N., BrownD. L., and BakerL. R. I.: Hematological Complications of Chlorate Poisoning, Brit. Med. J.1: 31 (Apr.) 1970.
84.
DacieJ. V., and WorlledgeS. M.: Auto-immune Hemolytic Anemias, Progress in Hematology6: 82, 1969.
85.
CooperbergA. A., and EidlowS.: Hemolytic Anemia, Jaundice and Diabetes Mellitus Following Chlorpromazine Therapy, Can. Med. Assoc. J.75: 746 (Nov.) 1956.
86.
LindbergL. G., and NardenA.: Severe Hemolytic Reaction to Chlorpromazine, Acta Med. Scand.170: 195 (July) 1961.
SummerlinW. T., WalderA. I., and MoncriefJ. A.: White Phosphorus Burns and Massive Hemolysis, J. Trauma7: 476 (No. 3) 1967.
93.
MatterB. J., PedersonJ., and PsimenosG.: Lethal Copper Intoxication in Hemodialysis, Trans. Am. Soc. Artif. Intern. Organs15: 309, 1969.
94.
IvanovichP., ManzlerA., and DrakeR.: Acute Hemolysis Following Hemodialysis, Trans. Am. Soc. Artif. Intern. Organs15: 316, 1969.
95.
ManzlerA. D., and SchreinerA. W.: Copper Induced Hemolytic Anemia, Ann. Intern. Med.73: 409 (Sept.) 1970.
96.
KleinW. J., MetzE. N., and PriceA. R.: Acute Copper Intoxication, Arch. Intern. Med.129: 578, 1972.
97.
YonetH. M., ViglinanoE. M., and HorowitzH. I.: Acute Hemolytic Anemia Associated With Administration of Alkylating Agents: Report of Two Cases Due to Cyclophosphamide and review of the literature, Am. J. Med. Sci.254: 70 (July) 1967.
98.
LoweJ.: Treatment of Leprosy With Diamino-Diphenyl Sulphone by Mouth, Lancet1: 145 (Jan.) 1950.
99.
RamanujamK., and SmithM.: Hemolytic Anemia During Treatment With Diaminodiphenylsulfone by Mouth, Lancet1: 21 (Jan.) 1951.
100.
AlldayE. J., and BarnesJ.: Toxic Effects of Diaminodiphenylsulfone in Treatment of Leprosy, Lancet2: 205 (Aug.) 1951.
101.
AlexanderJ.: Dapsone in the Treatment of Dermatitis Herpetiformis, Lancet1: 1201 (June) 1955.
102.
MorganJ. K., MarsdenC. W., CoburnJ. G., and MungavinJ. M.: Dapsone in Dermatitis Herpetiformis, Lancet1: 1197 (June) 1955.
103.
SmithR. S., and AlexanderS.: Heinz Body Anemia Due to Dapsone, Brit. Med. J.1: 625 (Mar.) 1959.
104.
LorinczA. L., and PearsonR. W.: Sulfapyridine and Sulfone Type Drugs in Dermatology, Arch. Dermatol.85: 42 (Jan.) 1962.
105.
PengellyC. D. R.: Dapsone Induced Hemolysis, Brit. Med. J.2: 662 (Sept.) 1963.
106.
GisslenH., and HersleK.: Laboratory Investigation in Sulphone-Induced Hemolytic Anemia, Brit. J. Dermatol.76: 315 (July) 1964.
107.
VianiH., and HollandP. D. J.: The Control of Dapsone Heinz Body Anemia With Adrenal Corticosteroids, Brit. J. Dermatol.76: 63 (Feb.) 1964.
108.
DeGowinR. L., EppesR. B., PowellR. D., and CarsonP. E.: Studies on Sulfone-Induced Hemolysis, Clin. Res.13: 270 (Apr.) 1965.
109.
McNamaraJ. V., EppesR. B., PowellR. D., and CarsonP. E.: The Effects of Para-Aminobenzoic Acid on the Hemolytic Effects of 4,4′-Diaminodiphenylsulfone, Mil. Med.131: 1057 (Sept.) 1966.
110.
DeGowinR. L., EppesR. B., PowellR. D., and CarsonP. E.: The Hemolytic Effects of Diphenylsulfone in Normal Subjects and in Those With Glucose-6-Phosphate Dehydrogenase Deficiency, Bull. WHO35: 165, 1966.
111.
SheechyT. W., RebaR. C., NeffT. A., GainterR., and TigerttW. D.: Supplemental Sulfone Therapy, Arch. Intern. Med.119: 561 (June) 1967.
112.
ChernofD.: Dapsone-Induced Hemolysis in G-6-PD Deficiency, J. Am. Med. Assoc.201: 554 (Aug.) 1967.
113.
CreamJ. J., and ScottG. L.: Anemia in Dermatitis Herpetiformis, Brit. J. Dermatol.82: 333 (Apr.) 1970.
114.
CrumblyJ. J.: Anemia Following Use of Antihistamine Drugs, J. Am. Med. Assoc.143: 726 (June) 1950.
115.
HollandP., and MauerA. M.: Diphenylhydantoin-Induced Hypersensitivity Reaction, J. Pediat.66: 322 (Feb.) 1965.
116.
HarinasutaU., and ZimmermanH. J.: Diphenylhydantoin Sodium Hepatitis, J. Am. Med. Assoc.203: 1015 (Mar.) 1968.
117.
McCreaT., and UlleryJ. C.: Favism; Report of a Case, J. Am. Med. Assoc.101: 1389 (Oct.) 1933.
118.
HuttonJ. E.: Favism; Unusually Observed Type of Hemolytic Anemia, 7. Am. Med. Assoc.109: 1618 (Nov.) 1937.
WhartonH. J., and DusselmanW.: Favism - a Short Review and Report of a Case, N. E. J. Med.236: 974 (June) 1947.
123.
RosenA. P., ScanlanJ. J.: Favism, N. E. J. Med.239: 367 (Sept.) 1948.
124.
LeeksH. I.: Favism - Report of a Case in a Child, J. Pediat.34: 309 (Mar.) 1949.
125.
JacobsA. H.: Favism in Two Children in California, Pediat.6: 51 (July) 1950.
126.
PickeringD. E., and HurwitzS.: Favism in Childhood; A Case Report, Yale J. Biol. Med.24: 5, 1951.
127.
WassermanE., and ChapmanR.: Favism, Conn. J. Med.15: 674 (July) 1951.
128.
LarkinV. P.: Favism, Report of a Case and Brief Review of the Literature, J. Pediat.42: 453 (Apr.) 1953.
129.
BeckerA. H.: Treatment of Favism With Cortisone, J. Am. Med. Assoc.155: 1158 (July) 1954.
130.
FrelickR. W., and BengeJ. H.: Favism; a Case Report. Del. Med. J.27: 73 (Apr.) 1955.
131.
McPheeW. R.: Acquired Hemolytic Anemia Caused by Ingestion of Fava Beans, Am. J. Clin. Path.26: 1287 (Nov.) 1956.
132.
CasperJ., and ShulmanJ.: Bilateral Cortical Necrosis of the Kidney in an Infant With Favism, Am. J. Clin. Path.26: 42 (Jan.) 1956.
133.
Chang-LiangChu, ChengNi Yang, and Ssu-YuanYang: Favism in Shanghai, Report of Two Cases, Clin. J. Pediat.7: 137, 1956.
134.
Ch'iWang, and Ch'ung-FangWang: Favism in Children in Kueiyang; Report of Four Cases, Chin. J. Pediat.7: 139, 1956.
135.
HarlyJ. D., and DodsL.: Hemolysis Following the Ingestion of Uncooked Broad Beans, Med. J. Aust.2: 561 (Oct.) 1957.
136.
Shuo-MingPu: Favism in Peking; Report of a Case and Review of the Literature, Chin. J. Intern. Med.5: 902, 1957.
137.
SzeinbergA., and Chari-BitromA.: Blood Glutathione Concentration in Cases With Past History of Hemolytic Anemia Due to Vicia fava or Sulfonamides, Acta Hemat.18: 229, 1957.
138.
TolmasH. C.: Favism. Case Report Showing Heredofamilial Tendency, J. Pediat.51: 445 (Oct.) 1957.
139.
ZinkhamW. H., LenhardR. E.Jr., and ChildB. A.: A Deficiency of Glucose-6-Phosphate Dehydrogenase Activity in Erythrocytes From Patients With Favism, Bull. Johns Hopkins Hasp.102: 169, 1958.
140.
MooreH. S.: A Suspected Case of Favism, Med. J. Aust.2: 733 (Nov.) 1958.
141.
BrooksE. A. V., JanusG. A., and StubberL. A.: Favism in Western Australia, Med. J. Aust.2: 455 (Oct.) 1958.
142.
SzeinbergA., AsherY., and ShebaC.: Studies on Glutathione Stability in Erythrocytes of Cases With Past History of Favism or Sulfa-Drug Induced Hemolysis, Blood13: 348 (Apr.) 1958.
143.
GrossR., HurwitzR., and MarksP.: An Hereditary Enzyme Defect in Erythrocyte Metabolism: Glucose-6-Phosphate Dehydrogenase Deficiency, J. Clin. Invest.37: 1176 (Aug.) 1958.
144.
Hsiao-HsiangChang: Favism: Clinical Analysis of 228 Cases, Chin. J. Pediat.10: 63, 1959.
145.
VellaT.: Favism in Asia, Med. J. Aust.2: 196 (Aug.) 1959.
146.
KantorS. Z., and ArbesmanC. E.: Serologic Studies on Favism, J. Allergy30: 114 (Mar.) 1959.
147.
HartiganJ. O., and GurnettT. J.: Favism, Report of a Case, J. Am. Med. Assoc.171: 299 (Sept.) 1959.
148.
RothK. L., and FruminA. M.: Studies on the Hemolytic Principle of the Fava Bean, J. Lab. Clin. Med.56: 695 (Nov.) 1960.
149.
PanzionF., and VueloC.: The Mechanism of Hemolysis in Favism, Acta Hemat.26: 337, 1961.
150.
EmanuelB., and SchoenfeldA.: Favism in a Nursing Infant, J. Pediat.58: 263 (Feb.) 1961.
151.
GreenbergM., and WongH.: Studies on the Destruction of Glutathione Unstable Red Blood CellsJ Lab Clin. Med.57: 733 (May) 1961.
152.
CahillK. M., and LeyA. B.: Favism and Thalassemia in a Pregnant Woman, J. Am. Med. Assoc.180: 119 (Apr.) 1962.
153.
HallB. E., PfuetzeK., HinshawH. C., and FeldmanW. H.: Effect of Promin on the Blood of Patients With Tuberculosis: Preliminary Report, Proc. Staff Meet. Mayo Clinic.17: 24 (Jan.) 1942.
154.
MengelC. E., KannH. E., and O'MalleyB.: Increased Hemolysis After Intramuscular Iron Administration in Patients With Paroxysmal Nocturnal HemoglobinuriaBlood26: 74 (July) 1965.
155.
RosseW. F., and GuttermanL. A.: The Effect of Iron Therapy in Paroxysmal Nocturnal HemoglobinuriaBlood36: 559 (Nov.) 1970.
156.
RobinsonM., and FoadioM.: Hemolytic Anemia With Positive Coombs' Test, J. Am. Med. Assoc.208: 656 (Apr.) 1969.
157.
SutherlandD. A., and EisentrautA. M.: The Direct Coombs' Test in Lead Poisoning, Blood11: 1024 (Nov.) 1956.
158.
ChisolmJ. J.Jr.: Lead Poisoning, Sci. Am.224: 15 (Feb.) 1971.
159.
CotziasG. C., and PapavasiliouP. S.: Autoimmunity in Patients Treated With Levodopa, J. Am. Med. Assoc.207: 2464 (Feb.) 1969.
160.
LobuglioA. F., MasouredisS. P., PisciottaA. O., PapavasiliouP. S., and CotziasG. C.: Characteristics of Red Cell Autoantibodies Induced by L-Dopa, Clin. Res.17: 333 (Apr.) 1969.
JosephC.: Occurrence of Positive Coombs' Test in Patients Treated With Levodopa, N. E. J. Med.286: 1401 (June) 1972.
163.
ChanT. K., MakL. W., and NgR. P.: Methemoglobinemia, Heinz Bodies, and Acute Massive Intravascular Hemolysis in Lysol Poisoning, Blood38: 739 (Dec.) 1971.
164.
RosenthalM. C., PisciottaA. V., KomnimosA. D., GoldenbergH., and DameshekW.: The Auto-immune Hemolytic Anemia of Lymphocytic Disease, Blood10: 197 (Mar.) 1955.
165.
HotchkissD. J.Jr.: Hemolytic Anemia and Thrombocytopenia in Chronic Lymphocytic Leukemia Following Nitrogen Mustard Therapy, Cancer19: 803 (June) 1966.
166.
ScottG. L., MylesA. B., and BaconP. A.: Autoimmune Hemolytic Anemia From Mefenamic Acid Therapy, Brit. Med. J.3: 534 (Aug.) 1968.
167.
JacksonJ. M., QuinlanJr., and GoatcherP.: Mefenamic Acid Induced Hemolytic Anemia, Brit. Med. J.2: 297 (May) 1970.
168.
FaridN. R., JohnsonR. J., and LowW. T.: Hemolytic Reaction to Mefenamic Acid, Lancet2: 382 (Aug.) 1971.
169.
RobertsonJ. H., KennedyG. C., and HillC. M.: Hemolytic Anemia Associated With Mefenamic Acid, Irish J. Med. Sci.140: 226 (May) 1971.
170.
EysterM. E.: Melphalan Erythrocyte Agglutinin and Hemolytic Anemia, Ann. Intern. Med.66: 573 (Mar.) 1967.
171.
AllisonA. C.: Danger of Vitamin K to Newborn, Lancet1: 669 (Mar.) 1955.
172.
AllisonA. C.: Acute Hemolytic Anemia With Distortion and Fragmentation of Erythrocytes in Children, Br. J. Hermat.3: 1, 1957.
173.
ZinkhamW. H.: Peripheral Blood and Bilirubin Values in Normal Full-term Primaquine-Sensitive Negroe Infants: Effect of Vitamin K, Pediat.31: 983 (June) 1963.
174.
MehtaB. C., MankodiR. P., AcharyaV.N.: Glucose-6-Phosphate Dehydrogenase Deficiency as a Cause of Drug-Induced Hemolysis With Renal Shutdown and Kernicterus, Can. J. Med. Sci.25: 308 (May) 1971.
175.
SnapperI., MarksD., SchwartzL., and HollanderL.: Hemolytic Anemia Secondary to Mesantoin, Ann. Intern. Med.36: 619 (Aug.) 1953.
176.
ShultsW. T., FountainE. N., and LynchE. C.: Methanethiol Poisoning, J. Am. Med. Assoc.211: 2153 (Mar.) 1970.
177.
CahulD. A.: Methyldopa and Hemolytic Anemia, Lancet1: 201 (Jan.) 1966.
178.
CoustairsL., WorlledgeS., DolleryC. T., and BreckenridgeA.: Methyldopa and Hemolytic Anemia, Lancet1: 201 (Jan.) 1966.
179.
DarnboroughJ.: Methyldopa and Hemolytic Anemia, Lancet1: 262 (Jan.) 1966.
180.
HayesD.: Methyldopa and Hemolytic Anemia, Lancet1: 365 (Feb.) 1966.
181.
SchwartzM., and Dige-PetersenH.: Methyldopa and Hemolytic Anemia, Lancet1: 434 (Feb.) 1966.
182.
HamiltonM., JenkinsG. C., and TurnbullA. L.: Methyldopa and Hemolytic Anemia, Lancet1: 549 (Mar.) 1966.
183.
PatonA.: Methyldopa and Hemolytic Anemia, Lancet1: 549 (Mar.) 1966.
184.
O'SheaR. F.: Hemolytic Anemia and Alpha Methyldopa, Med. J. Aust.1: 816 (May) 1966.
185.
WurzelH. A., and SilvermanJ. L.: Methyldopa and Hemolytic Anemia, Lancet1: 1158 (May) 1966.
186.
CramondE. H.: Haemolytic Anemia and Alpha-Methyldopa, Med. J. Aust.1: 995 (June) 1966.
187.
CarstairsK. C., BrekenbridgeA., DollergyC. T., and WorlledgeS. M.: Incidence of a Positive Direct Coombs' Test in Patients on Alpha-Methyldopa, Lancet2: 133 (July) 1966.
188.
WorlledgeS. M., CarstairsK. C., and DarcieJ. V.: Autoimmune Hemolytic Anemia Associated With Alpha-Methyldopa Therapy, Lancet2: 135 (July) 1966.
189.
Leading article: Methyldopa and Haemolytic Anemia, Lancet2: 151 (July) 1966.
190.
WeinerW., and PatonA.: Methyldopa and Haemolytic Anemia, Lancet2: 860 (Oct.) 1966.
191.
BuchananJ. G., RushB., and De GruckyG. C.: Methyldopa and Acquired Haemolytic Anemia, Med. J. Aust.2: 700 (Oct.) 1966.
192.
BrandtM. J., and LundT.: Methyldopa and Hemolytic Anemia, Lancet1: 771 (Apr.) 1966.
193.
CottonS.: Methyldopa and Haemolytic Anemia, Lancet2: 165 (July) 1966.
194.
CantorS., and BarnettA. J.: Hematological Effects of Methyldopa, Lancet1: 625 (Mar.) 1967.
195.
BelleM. S., and MasI. R.: Methyldopa and Positive Coombs' Test, J. Am. Med. Assoc.200: 900 (June) 1967.
196.
FeiziT., and WoodgateD.: The Direct Antiglobulin (Coombs') Test in Hypertensive Patients, Vox Sang.12: 273, 1967.
197.
LobuglioA. F., and JandiO. J. H.: The Nature of the Alpha Methyldopa Antibody, N. E. J. Med.276: 659 (Mar.) 1967.
198.
HopeJ. G., and ProvanG. C.: Hematological Effects of Methyldopa, Scot. Med. J.12: 229, 1967.
199.
LouisW. J., DoleA. E., and JerumsG.: Methyldopa and Haemolytic Anemia, Med. J. Aust.2: 104 (July) 1967.
200.
ShermanJ. D., LoveD. E., and HarringtonJ. F.: Anemia, Positive Lupus and Rheumatoid Factors With Methyldopa, Arch. Intern. Med.120: 321 (Sept.) 1967.
201.
ClarkK. G. A.: Hemolysis and Agranulocytosis Complicating Treatment With Methyldopa, Brit. Med. J.4: 94 (Oct.) 1967.
202.
JaffeB. I., SpitzI. M., and GaleG. E.: Autoimmune Hemolytic Anemia Associated With Alpha Methyldopa Therapy, A Case Report. S. Afr. Med. J.41: 907, 1967.
203.
DolleryC. T., WorlledgeS. M., HelborowE. J., and JohnsonG. D.: Positive Direct Coombs' Tests and Antinuclear Factors in Patients Treated With Methyldopa, Lancet2: 1265 (Dec.) 1967.
204.
CroftJ. D., SwisherS. N., GillilandB. C., BakemeirR. F., LeddyJ. P., and WeedR. I.: Coombs' Test Positivity Induced by Drugs, Ann. Intern. Med.68: 176 (Jan.) 1968.
205.
HamiltonM.: Some Aspects of the Long-Term Treatment of Severe Hypertension With Methyldopa, Postgrad. Med. J.44: 66 (Jan.) 1968.
206.
HedgeJ. V., and CasyT. P.: Methyldopa and the Direct Antiglobulin Test, New Zealand Med. J.68: 240, 1968.
WurzelH. A., and SilvermanJ. L.: The Effects of Alpha Methyl-3, 4-Dihydroxy L-Phenylalanine on Erythrocytes, Transfusion8: 84 (Mar.-Apr.) 1968.
209.
EwingD. J., HughesC. J., and WaudleD. F.: Methyldopa Induced Autoimmune Hemolytic Anemia - a Report of Two Further Cases, Guy's Hasp. Rep.117: 111, 1968.
210.
MuradF.: Immunophemolytic Anemia During Therapy With Methyldopa, J. Am. Med. Assoc.203: 149 (Jan.) 1968.
211.
FeltkampT. E. W., EngelfrietC. P., and Van LoghornJ. J.: Autoantibodies and Methyldopa, Lancet1: 644 (Mar.) 1968.
212.
BakcmeirR. F., and LeddyJ. P.: Erythrocyte Autoantibody Associated With Alpha Methyldopa: Heterogenecity of Structure and Specificity, Blood32: 1 (July) 1968.
213.
KlapperM. S., and NotoT. A.: Positive Direct Antiglobin Reactions and Methyldopa, Ala. J. Med. Sci.5: 421, 1968.
214.
SassettiR. J.: Red Cell and Protein Binding of Alpha Methyldopa, J. Lab. Clin. Med.72: 1013 (Dec.) 1968.
215.
HarthM.: L. E. Cells and Positive Direct Coombs' Test Induced by Methyldopa, Can. Med. Assoc. J.99: 277 (Aug.) 1968.
216.
MackayI. R., CowlingD. C., and HurlyT. H.: Drug-Induced Autoimmune Disease: Hemolytic Anemia and Lupus Cells After Treatment With Methyldopa, Med. J. Aust.2: 1047 (Dec.) 1968.
217.
WorlledgeS. M.: Autoantibody Formation Associated With Methyldopa Therapy, Brit. J. Haematol.16: 5 (Jan.) 1969.
218.
VyasG. N., SassettiR. J., PetzL. D., and FudenbergH. H.: Experimental Study of Aldomet-Induced Positive Antiglobin Reaction, Brit. J. Hematol16: 137 (Jan.) 1969.
SpicimannW.: Positive Direct Coombs' Test and Alpha-Methyldopa, Klin. Wschr.47: 325, March 1969.
221.
DistenfeldA., FloritaC., and GelfandM. L.: Hemolytic Anemia Induced by Alpha Methyldopa, New York St. J. Med.70: 570 (Feb.) 1970.
222.
Vda De TorregrossaM., BullsA. G., and RiveraA. A.: Coombs-Positive Drug-Induced Hemolytic Anemia, Am. J. Clin. Path.53: 490 (Apr.) 1970.
223.
EkinonS.: Hemolytic Anemia After Treatment With Methyldopa, Lakartidningen67: 5866 (Dec.) 1970.
224.
RobinsonS.: Acquired Hemolytic Anemia With Unusual Serological Characteristics, Can. J. Med. Technol.32: 188 (Oct.) 1970.
225.
ChenC. S., and ChunT. K.: Direct Coombs' Test and Methyldopa, Lancet12: 881 (Oct.) 1971.
226.
HunterE., RaikE., and GordonS.: Incidence of Positive Coombs' Test, le. Cells and Antinuclear Factor in Patients on Alpha Methyldopa Therapy, Med. J. Aust.2: 810 (Oct.) 1971.
AbelsonS. M., and HendersonA. T.: Moth-Ball Poisoning, U.S. Armed Forces Med. J.2: 491, 1951.
243.
SchaferW. B.: Acute Hemolytic Anemia Related to Naphthalene. Report of a Case in a Newborn Infant, Pediat.7: 172 (Feb.) 1951.
244.
MackellJ. V., RiedersF., BriegerH., and BawerE.: Acute Hemolytic Anemia Due to Ingestion of Naphthalene Moth Balls, Pediat.7: 722 (May) 1951.
245.
MacGregorR. R.: Naphthalene Poisoning From the Ingestion of Moth Balls, Can. Med. Assoc. J.70: 313 (Mar.) 1954.
246.
ChusidE., and FriedC. T.: Acute Hemolytic Anemia Due to Naphthalene Ingestion, Am. J. Dis. Child.89: 612, 1955.
247.
HaggertyR. J.: Naphthalene Poisoning, N. E. J. Med.255: 919 (Nov.) 1956.
248.
GidronE., and LeurerJ.: Naphthalene Poisoning, Lancet1: 228 (Feb.) 1956.
249.
CockT. C.: Acute Hemolytic Anemia in the Neonatal Period, J. Dis. Child.94: 77, 1957.
250.
ZimkhamW. H., and ChildsB.: Effect of Vitamin K and Naphthalene Metabolites on Glutathione Metabolism of Erythrocytes From Normal Newborns and Patients With Naphthalene Hemolytic Anemia, J. Dis. Child.94: 420, 1957.
251.
YoumisD., VeltsosA., PlatakosTH., and VafiadisS.: Clinical and Laboratory Study of Cases of Naphthalene Intoxication, Arch. Inst. Pasteur Helleninque521, 1957.
252.
ZinkhamW. H., and ChildsB.: Effect of Naphthalene Derivatives on Glutathione Metabolism of Erythrocytes From Patients With Naphthalene Hemolytic Anemia, J. Clin. Inves.36: 938, (Mar.) 1957.
253.
DawsonJ. P., ThayerW. W., and DesforgesJ. F.: Acute Hemolytic Anemia in the Newborn Infant Due to Naphthalene Poisoning: Report of Two Cases, With Investigations Into the Mechanisms of the Disease, Blood13: 1113 (Dec.) 1958.
254.
ZimkhamW. H., and ChildsB.: A Defect of Glutathione Metabolism in Erythrocytes From Patients With Naphthalene-Induced Hemolytic Anemia, Pediat.22: 461 (Sept.) 1958.
255.
ValaesT., DoxiadisS. A., and FessasP.: Acute Hemolysis Due to Naphthalene Inhalation, J. Pediat.63: 904 (Nov.) 1963.
256.
WestM., and ZimmermanH. J.: Hemolytic Anemia in Patient Receiving Nitrofurantoin, J. Am. Med. Assoc.162: 637 (Oct.) 1956.
257.
KimbroE.Jr.: The Mechanism of Hemolytic Anemia Induced by Nitrofurantoin, Bull. Johns Hopkins Host.101: 245, 1957.
258.
LevyD., and PorgessA.: Hemolytic Anemia in a Child Receiving Nitrofurantoin, Arch. Dis. Child.33: 5271958.
259.
GarrettJ. V., HallumJ., and ScottP.: Urinary Antiseptics Causing Hemolytic Anemia in Pregnancy in a West Indian Woman With Red Cell Enzyme Deficiency, J. Obstet. Gynocol. Brit. Com.70: 1073 (Dec.) 1963.
260.
PowellR. D., and DeGowinR. L.: Nitrofurantoin Induced Hemolysis, J. Lab. Clin. Med.62: 1002 (Dec.) 1963.
261.
DeVeberL. L., and ValentineG. H.: Nitrofurantoin and Megaloblastic Anemia, Lancet2: 697 (Sept.) 1964.
262.
PritchardJ. A., ScottD. E., and MasonR. A.: Severe Anemia With Hemolysis and Megaloblastic Erythropoiesis, J. Am. Med. Assoc.194: 457 (Oct.) 1965.
263.
HibbardL., ThruppL., SummerilS., SmaleM., and AdamsR.: Treatment of Pyelonephritis in Pregnancy, Am. J. Obstet. Gynecol.9: 609 (July) 1967.
264.
StefanineM.: Acute Drug-Induced Hemolytic Anemia Related to Erythrocyte Enclose Deficiency, J. Am. Med. Assoc.212: 868 (May) 1970.
265.
CarpelE.: Hemolysis Induced by Nitrofurantoin, Penn. Med.73: 49 (May) 1970.
266.
Koch-WesserJ., SidelV. W.;,: Adverse Reactions to Sulfisoxazole, Sulfamethoxazole, and Nitrofurantoin, Arch. Intern. Med.128: 399 (Sept.) 1971.
267.
RobertsonD. H. H.: Nitrofurazone Induced Hemolytic Anemia, Ann. Trop. Med. Parasitol.55: 49 (Apr.) 1961.
268.
ConradM. E., KnochelJ. P., and CrosbyW. H.: Novobiocin Jaundice: Demonstration of a Hemolytic State, Antibiotic Med.7: 382 (Jan.) 1960.
269.
MontgomeryJ. R.: Hemolytic Reaction After Novobiocin Therapy, N. E. J. Med.277: 966 (Oct.) 1967.
270.
CordesW.: Experiences With Plasmochin in Malaria (Preliminary Reports), 15th annual report, United Fruit Co. (Med. Dept.) pp. 66, 1926.
271.
CordesW.: A Death in a Case of Malarial Fever Undergoing Treatment With Plasmochin Compound, 15th annual report, United Fruit Co. (Med. Dept.) pp. 72, 1926.
272.
CordesW.: Observations on the Toxic Effect of Plasmochin, 16th annual report, United Fruit Co. (Med. Dept.) pp. 62, 1927.
BrosiusO. T.: Plasmochin in Malaria, 16th annual report, United Fruit Co. (Med. Dept.) pp. 26, 1927.
275.
Manson-BahrP.: The Action of Plasmochin on Malaria, Proc. Roy. Soc. Med.20: 919, 1927.
276.
BrosiusO. T.: Plasmochin in Malaria, 17th annual report, United Fruit Co. (Med. Dept.) pp. 51, 1928.
277.
CordesW.: Zwischenfalle bei der Plasmochinbehandlung, Arch. f. Schiffs u. Tropen. Hyg.32: 143, 1928.
278.
MenkW.: Combined Quinine and Plasmochin Treatment for Malaria in Haitian Negroes, 16th annual report. United Fruit Co. (Med. Dept.) 78, 1928.
279.
NamikawaH.: Symptoms of Poisoning in the Treatment of Malaria, Taiwan Igakkai Zasshi284: 15, 1928.
280.
PalmaM.D.: Considerazioni sulla Plasmochinaterapia della Malaria, Riforma Med.44: 753, 1928.
281.
RoskottE. R. A. L., and SenoR.: Ervaringen met Plasmochin, Gennesk. Tijkdschr. v. Nederl.-Indie68: 80, 1928.
282.
BaermannG., and SmitsE.: Uber Plasmochin, II. Mitt. Arch. f. Schiffs.u. Tropen-Hygiene33: 24, 1929.
283.
FreimanM.: Plasmoquine and Plasmoquine Compound in the Treatment of Malaria, J. Trop. Med. Hyg.32: 165, 1929.
284.
KliglerI. J., and ReitlerR.: Studies in Malaria. IV. Prophylactic Use of Plasmochin in a Bedouin Population, Riv. di malaria.8: 28, 1929.
285.
ManaiA.: Ittero de Plasmochina, Policlinico (sez. prot.) 36: 1215, 1929.
286.
ManifoldJ. A.: Report on a Trial of Plasmoquine and Quinine in the Treatment of Benign Tertain Malaria, J. Roy. Army Med. Corps56: 321, 1931.
287.
DixonH. B. F.: A Report on Six-Hundred Cases of Malaria Treated With Plasmoquine and Quinine, J. Roy. Army Med. Corps60: 431, 1933.
288.
AmyA. C.: Hemoglobinuria: A New Problem on the Indian Frontier, J. Roy. Army Med. Corps62: 178, 269 318, 1934.
289.
MissiroliA., and MarinoP.: Anwendung des Chinoplasmin zur Malaria-Sanierung, Arch. f. Schiffs u. Tropenhyg.38: 1, 1934.
290.
BlackieW. K.: A Fatal Case of Plasmoquine Poisoning, S. Air. Med. J.9: 147, 1935.
291.
FicacciL.: Emoglobinuria da Plasmochina, II. Policlinoco42: 136, 1935.
292.
SeinM.: Case of Hemoglobinuria Caused by Plasmochin, Taken as Prophylactic Against Malaria, Indian Med. Gaz.72: 86, 1937.
293.
MannN., and SmithS.: Hemoglobinuria Following the Administration of Plasmoquine, Trans. Roy. Soc. Trop. Med. Hyg.37: 151, 1943.
294.
SwantzH. E., and BaylissM.: Hemoglobinuria: Report of Ten Cases of Its Occurrence in Negroes During Convalescence From Malaria, War. Med.7: 104, 1945.
295.
DimsonS. B., and McMartinR. B.: Pamaquine Haemoglobinuria, Quart. J. Med.15: 25, 1946.
296.
HardgroveM., and ApplebaumI. L.: Plasmochin Toxicity: Analysis of 258 Cases, Ann. Intern. Med.25: 103 (July) 1946.
297.
FeldmanH. A., PackerH., MurphyF. D., and WatsonR. B.: Pamaquine Naphthoate as a Prophylactic for Malarial Infections, J. Clin. Invest.26: 77 (Jan.) 1947.
298.
EarleD. P.Jr., BieglowF. S., ZubrodC. G., and KaneC. A.: Studies on the Chemotherapy of the Human Malarias. IV. Effect of Pamaquine on the Blood Cells of Man, J. Clin. Invest. (Supplement), 27: 121 (May) 1948.
299.
KengKho Lien: Een Geval Van Zwartwaterkoots met Cyanose (Methaemglobinaemie), Waarschijnlijk door Plasmochine, Med. Maandblad1: 342, 1948.
300.
WarthinT. A., LevineS. A., and EvansR. A.: Malaria; Observations on Treatment With Chloroquine (SN 7618) and Combined Quinine and Plasmochin, N. E. J. Med.238: 467 (Apr.) 1948.
301.
GarrisonP. L., HankeyD. D., CokerW. G., DonovanW. N., and JastremskiB.: Cure of Korean Viral Malaria With Pamaquine and Primaquine, J. Am. Med. Assoc.199: 1562 (Aug.) 1952.
302.
BeutlerE.: The Hemolytic Effect of Primaquine and Related Compounds: a Review, Blood14: 103 (Feb.) 1959.
303.
LeyA. B., CahanA., and MayerK.: Proceedings of the Seventh Congress of the International Society of Blood Transfusion, Rome. 539, 1958.
304.
StrumiaP. V., and RaymondF. D.: Acquired Hemolytic Anemia and Antipenicillin Antibody, Arch. Intern. Med.109: 603 (May) 1962.
305.
BeardwellC. G.: Acute Hemolytic Anemia With Antipenicillin Antibodies Complicating Subacute Bacterial Endocarditis, Proc. Roy. Soc. Med.57: 332 (Apr.) 1964.
306.
VanarsdaleP. P., and GillilandB. C.: Anemia Secondary to Penicillin Treatment: Studies on Two Patients With “Non-Allergic” Serum Hemaglutinins, J. Lab. Clin. Med.65: 277 (Feb.) 1965.
307.
ClaytonE. M., AltshulerJ., and BoneJ. R.: Penicillin Antibody as a Course of Positive Direct Antiglobulin Tests, Am. J. Clin. Path.44: 646 (Dec.) 1965.
308.
PetzL. D., and FudenbergH. H.: Coombs-Positive Hemolytic Anemia Caused by Penicillin Administration, N. E. J. Med.274: 171 (Jan.) 1966.
309.
SwansonM. A., ChanmouganD., and SchuartzR. S.: Immunohemolytic Anemia Due to Antipenicillin Antibodies, N. E. J. Med.274: 178 (Jan.) 1966.
310.
RosnerF., LaiM., and RitzN.: Hemolytic Anemia Due to Penicillin Hypersensitivity, N. E. J. Med.274: 973 (Apr.) 1966.
311.
LaiM., RosnerF., and RitzN. D.: Hemolytic Anemia Due to Antibodies to Penicillin, J. Am. Med. Assoc.198: 483 (Oct.) 1966.
NesmithL. W., and DavisJ. W.: Hemolytic Anemia Caused by Penicillin, J. Am. Med. Assoc.203: 27 (Jan.) 1968.
314.
LyonL. J.: Coombs' Positive Hemolytic Anemia Due to Penicillin, J. Mt. Sinai Hosp. N.Y.35: 258 (May-June) 1968.
315.
WhiteJ. B., BrownD. L., HepnerG. W., and WorkledgeS. M.: Penicillin-Induced Haemolytic Anemia, Brit. Med. J.2: 26 (July) 1968.
316.
AmosH. E., BishopA. N. R., SeamanM. J., and TrowellJ.: Penicillin-Induced Hemolytic Anemia, Brit. Med. J.3: 436 (Aug.) 1968.
317.
RoyR. B., DorisL., and BeanlandsD. S.: Positive Direct Coombs' Test Without Hemolytic Anemia Attributed to Penicillin Therapy, Can. Med. Assoc. J.99: 321 (Aug.) 1968.
318.
RossiterM. A., GrayI. R., and ShintonN. K.: Penicillin-Induced Hemolytic Anemia, Brit. Med. J.3: 616 (Sept.) 1968.
319.
SilvermanN.H.: Penicillin-Induced Hemolytic Anemia: A Case Report, S. Afr. Med. J.44: 1247 (Oct.) 1970.
320.
ParkerJ. C., and BarrettD. A.: Microangiopathic Hemolysis and Thrombocytopenia Related to Penicillin Drugs, Arch. Intern. Med.127: 474 (Mar.) 1971.
321.
BooneA. W.: Penicillin-Induced Hemolytic Anemia, J. Maine Med. Assoc.62: 287 (Dec.) 1971.
322.
LoebR. F.: Activity of a New Antimalarial Agent, Pentaquine (SN-13,276) Statement Approved by the Board for Coordination of Malarial Studies, J. Am. Med. Assoc.132: 321 (Oct.) 1946.
323.
AlvingA. S.: Pentaquine (SN-13,276) and Isopentaquine (SN-13,274), Therapeutic Agents Effective in Reducing Relapse Rate in Viral Malaria, Washington, D.C., Proc. Fourth International Congress on Tropical Medicine and Malaria. May 10–18, 1948.
324.
AtchleyJ. A., YauntE. H., HustedJ. R., PullmanT. N., AlvingA. S., and EichelbergerL.: Reactions Observed During Treatment With Pentaquine, Administered With Quinaquine. (Atabrine) Metachloridine (SN-11,437) and With Sulfadiazine, J. Nat. Malaria Soc.7: 118, 1948.
325.
CoatneyG. R., CooperW. C., EylesD. E., CalwellW. B., WhiteW. C., and LintsH. A.: Studies in Human Malaria. XXVII. Observations on the Use of Pentaquine in the Prevention and Treatment of Chesson Strain Vivax Malaria, J. Nat. Malaria Soc.9: 222, 1950.
326.
CrawfordS. E., MoonA. E., and PanosT. C.: Methemoglobinemia Associated With Pyridium Administration, J. Am. Med. Assoc.146: 24 (May) 1951.
327.
GreenbergM. S., and WongH.: Methemoglobinemia and Heinz Body Hemolytic Anemia Due to Phenazopyridine Hydrochloride, N. E. J. Med.271: 431 (Aug.) 1964.
328.
GaborE. P., LowensteinL., and De LeeuwN. K. M.: Hemolytic Anemia Induced by Phenylazo-diamino-pyridine (Pyridium), Can. Med. Assoc. J.91: 756 (Oct.) 1964.
329.
WanderH. J., and PascoeD. J.: Phenylazopyridine Hydrocholide Poisoning, Am J. Dis. Child.110: 105 (July) 1965.
330.
EisingerA. J., and JonesR.: Phenazopyridine-Hydro-chloride Hemolysis, Lancet1: 151 (Jan.) 1969.
331.
CohenB. L., and BovassoG. J.: Acquired Methemoglobinemia and Hemolytic Anemia Following Excessive Pyridium Ingestion, Clin. Pediat.10: 537 (Sept.) 1971.
332.
BrownG. C., and GiffinH.: The Treatment of Polycythemia Vera With Phenylhydrizene, Arch. Intern. Med.38: 321 (Sept.) 1926.
333.
StatsD., WassermanL. R., and RosenthalN.: Hemolytic Anemia With Hemoglobinuria, Am. J. Clin. Path.18: 757 (Oct.) 1948.
334.
AlvingA. S., ArnoldJ., and RobinsonD. H.: Status of Primaquine, J. Am. Med. Assoc.149: 1448 (Aug.) 1952.
335.
BeutlerE., DernR. J., and AlvingA. S.: The Hemolytic Effect of Primaquine, J. Lab. Clin. Med.44: 171 (Aug.) 1954.
336.
DernR. J., BeutlerE., and AlvingA. S.: The Hemolytic Effect of Primaquine, J. Lab. Clin. Med.44: 171 (Aug.) 1954.
337.
DernR. J., WeinsteinI. M., LeRoyG. V., TalmangeD. W., and AlvingA. S.: The Hemolytic Effect of Primaquine, J. Lab. Clin. Med.43: 303 (Feb.) 1954.
338.
CarsonP. E., BrewerG. J., and IckesC.: Decreased Glutathione Reductase With Susceptibility to Hemolysis, J. Lab. Clin. Med.55: 804 (Nov.) 1961.
339.
ZailS. S., CharltonR. W., and BothwellT. H.: The Hemolytic Effect of Certain Drugs in Bantu Subjects With a Deficiency of Glucose-6-Phosphate Dehydrogenase, S. Afr. J. Med. Sci.27: 95 (Jan.) 1962.
340.
BrewerG. J., PowellR. D., SwansonS. H., and AlvingA. S.: Hemolytic Effect of Primaquine, J. Lab. Clin. Med.64: 602 (Oct.) 1964.
341.
SalvidioE., PanaacciullI., TizianelloA., and AjmarF.: Nature of Hemolytic Crisis and the Fate of G6PD Deficient Drug Damaged Erythrocytes in Sardinians, N. E. J. Med.276: 1339 (June) 1967.
342.
LeavittT. J., MoriganT. C., and FreemanJ. M.: Hemolytic Uremic-Like Syndrome Following Polycarboxylate Interferon Induction, Am. J. Dis. Child.121: 43 (Jan.) 1971.
343.
FriedmanA. L., BarrP. S., and BrodyE. A.: Hemolytic Anemia Due to Quinidine: Observation on Its Mechanism, Am. J. Med.20: 806 (May) 1956.
344.
EscobarM. A., HellerP., and TrobaughF. E.: “Complete” Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency, Arch. Intern. Med.113: 426 (Mar.) 1964.
345.
AdnerM. M., AlstattL. B., and ConradM. E.: Coombs' Positive Hemolytic Disease in Malaria, Ann. Intern Med.68: 33, (Jan.) 1968.
346.
SpriggsA. I., SmithR. S., GriffithH., and TrueloveS. C.: Heinz Body Anemia Due to Salicylazosulphapyridine, Lancet1: 1039 (May) 1958.
347.
ShintonN. K., and WilsonC.: Autoimmune Hemolytic Anemia Due to Phenacetin and p-Amiosalicylic AcidLancet1: 226 (Jan.) 1960.
348.
GardnerM.D., and BargenJ. A.: Hemolytic Anemia Secondary to Salicylazosulfapyridine Therapy, 7. Am Med Assoc.190: 71 (Oct.) 1964.
349.
CohenS. M., RosenthalD. S., and KarpP. J.: Ulcerative Colitis and Erythrocyte G6PD Deficiency, J. Am Med. Assoc.205: 528 (Aug.) 1968.
350.
OldhamR. R., WangY. M., Van EysJ., and CarterJ.: Hemolytic Crisis in a Patient Treated With Santonin, S. Med. J.64: 460 (Apr.) 1971.
351.
HarrisJ. W.: Studies on the Mechanism of a Drug-Induced Hemolytic Anemia, J. Lab. Clin. Med.44: 809 (Nov.) 1954.
352.
HarrisJ. W.: Studies on the Mechanism of a Drug-Induced Hemolytic Anemia, J. Lab. Clin. Med.47: 760 (May) 1956.
353.
Vda de TorregrosaM. V., RosadoA. L. R., and MontillaE.: Hemolytic Anemia Secondary to Stibophen Therapy, J. Am. Med. Assoc.186: 596 (Nov.) 1963.
De LeeuuN. K. M., ShapiroL., and LowensteinL.: Drug-Induced Hemolytic Anemia, Ann. Intern. Med.58: 592 (Apr.) 1963.
356.
RiederR. F., ZinkhamW. H., and HeltzmanN. A.: Hemoglobin Zurich, Am. J. Med.39: 4 (July) 1965.
357.
BoyerN. H.: Acute Hemolytic Anemia Following Sulfadiazine: Report of a Case, N. E. J. Med.228: 566 (May) 1943.
358.
DameshekW.: Cold Hemagglutinens in Acute Hemolytic Reactions in Association With Sulfonamide Medication and Infection, J. Am. Med. Assoc.123: 77 (Sept.) 1943.
359.
DowlingH. F., and LepperM. H.: Toxic Reactions Following Therapy With Sulfapyridine, Sulfathiazole and Sulfadiazine, J. Am. Med Assoc.121: 1190 (Apr.) 1943.
360.
LayneJ. A., and SchemmF. R.: Acute Macrocytic Anemia Following Administration of Sulfadiazine, J. Lab. Clin. Med.29: 347 (Apr.) 1944.
361.
DonaldD., and WunschR. E.: Acute Hemolytic Anemia With Toxic Hepatitis Caused by Sulfadiazine: Report of a Case, Ann. Intern. Med.21: 709 (Oct.) 1944.
362.
RossJ. F., and PaegelB. L.: Acute Hemolytic Anemia and Hemoglobinuria Following Sulfadiazine Administration, Blood1: 189, 1946.
363.
FrickP. G., HitzigW. H., and BetkeK.: Hemoglobin Zurich. I. A New Hemoglobin Anomaly Associated With Acute Hemolytic Episodes With Inclusion Bodies After Sulfonamide Therapy, Blood20: 261 (Sept.) 1962.
GrechJ. L., and CachiaE. A.: Acute Haemolytic Anemia Associated With Sulphadimidine Therapy, Brit. Med. J.4: 1309 (Dec.) 1959.
366.
HayesD. M., and FeltsJ. H.: Sulfonamide Methemoglobinemia and Hemolytic Anemia During Renal Failure, Am. J. Med. Sci.247: 552 (May) 1964.
367.
AllenS. D., and WilkersonJ. L.: The Importance of Glucose-6-Phosphate Dehydrogenase Screening in a Urologic Practice, J. Urol.107: 304 (Feb.) 1972.
368.
BrownA. K., and CevikN.: Hemolysis and Jaundice in the Newborn Following Maternal Treatment With Sulfamethoxypyridazine (Kynex), Pediat.36: 742 (Nov.) 1965.
369.
HarveyA. M., and JanewayC. A.: The Development of Acute Hemolytic Anemia, J. Am. Med. Assoc.109: 12 (July) 1937.
370.
KohnS. E.: Acute Hemolytic Anemia During Treatment With Sulfanilamide, J. Am. Med. Assoc.109: 1005 (Sept.) 1937.
371.
WoodW. B.: Anemia During Sulfanilamide Therapy, J. Am. Med Assoc.111: 1916 (Nov.) 1938.
372.
WillisT.: Sulfanilamide in Ophthalmia Neonatorum, Yale J. Biol. Med.10: 275 (Jan.) 1938.
373.
WoodH.: A Fatality From Acute Hemolytic Anemia Which Developed During the Administration of Sulfanilamide, S. Med. J.31: 646 (June) 1938.
374.
AntopolW., ApplebaumI., and GoldmanL.: Two Cases of Acute Hemolytic Anemia With Auto-Agglutination Following Sulfanilamide Therapy, J. Am. Med Assoc.113: 488 (Aug.) 1939.
375.
SpringM., and BernsteinI.: The Coexistence of Toxic Hepatitis, Acute Hemolytic Anemia and Renal Damage Following Sulfanilamide Therapy: Report of Two Cases, Ann. Intern. Med.14: 153 (July) 1940.
376.
LongP., HavilandJ. W., EdwardsL. B., and BlissE. A.: The Toxic Manifestations of Sulfanilamide and Its Derivatives, J. Am. Med. Assoc.115: 364 (Aug.) 1940.
377.
MyersG. B., and RomJ.: Acute Hemolytic Anemia, Hemoglobinuria and Uremia Following Sulfanilamide, Ann. Intern. Med.14: 164 (July) 1940.
378.
WatsonC. J., and SpinW. W.: Effect of Sulfanilamide and Sulfapyridine on Hemoglobin Metabolism and Hepatic Function, Arch. Intern. Med.65: 825 (Apr.) 1940.
DacieJ. V.: Hemolytic Reaction to Drugs, Proc. Roy. Soc. Med.55: 28 (Jan.) 1962.
381.
RichardsonR. L., GeramiS., ColeF. H.: G-6-PD Deficiency, Sickle Cell Trait, and Acute Hemolysis After Bronchography, J. Am. Med Assoc.210: 1922 (Dec.) 1969.
382.
RavidJ. M., and ChesnerC.: A Fatal Case of Hemolytic Anemia and Nephrotic Uremia Following Sulfapyridine Administration, Am. J. Med. Sci.199: 380 (Mar.) 1940.
383.
RothsteinI., and CohenS.: Acute Hemolytic Anemia, Autoagglutination, Toxic Hepatitis and Renal Damage Following Sulfathiazole Therapy: Case Report, Ann. Intern. Med.16: 152 (Jan.) 1942.
384.
NewtonW. A., and BassJ. C.: Glutathione Sensitive Chronic Nonspherocytic Hemolytic Anemia, Am. J. Dis. Child.96: 501 (Oct.) 1958.
385.
RigasD. A., and KalerR. D.: Decreased Erythrocyte Survival in Hemoglobin H Disease as a Result of the Abnormal Properties of Hemoglobin H: The Benefit of Splenectomy, Blood.18: 1 (July) 1961.
DesforgesJ. F., ThayerW. W., and DawsonJ. P.: Hemolytic Anemia Induced by Sulfoxone Therapy With Investigations into the Mechanism of Its Production, Am. J. Med.27: 132 (July) 1959.
388.
GoluboffN., and WheatonR.: Methylene Blue Induced Cyanosis and Acute Hemolytic Anemia Complicating the Treatment of Methemoglobinemia. J. Pediat.58: 86 (Jan.) 1961.
389.
RosenP. J., JohnsonC., McGeheeW. G., and BeutlerE.: Failure of Methylene Blue Treatment in Toxic Methemoglobinemia, Ann. Intern. Med.75: 83 (July) 1971.
390.
TeunisB. S., LeftwichE. I., and PierceL. E.: Acute Methemoglobinemia and Hemolytic Anemia Due to Toluidine Blue, Arch. Surg.101: 527 (Oct.) 1970.
391.
LewisF. B., SchwartzR. S., and DamesheckW.: X-radiation and Alkylating Agents as Possible Trigger Mechanisms in the Autoimmune Complications of Malignant Lymphoproliferative Disease, Soc. Exp. Immunol.1: 3 (Jan.) 1966.
392.
MacDonaldC. A., and LackerM. J.: Oral Vinblastine Sulfate in Hodgkin's Disease, Clin. Pharmacol. Ther.7: 534 (July-Aug.) 1966.